PMC8213496_01
Mean fluorescence intensity of posttransplant donor-specific antibodies to donor human leukocyte antigens.
CRIT2021-6637154.001.jpg
PMC8213496_01_CRIT2021-6637154.001.jpg
fig1
She continued to have serial DSA analysis (Figure 1), which showed mainly class II DSAs with low MFIs.
Posttransplant pulmonary function. FEV1: forced expiratory volume in one second; FEV1/FVC: forced expiratory volume in one second/forced vital capacity ratio; FEF25-75: mid-expiratory flow rate; FVC: forced vital capacity.
CRIT2021-6637154.002.jpg
PMC8213496_01_CRIT2021-6637154.002.jpg
fig2
From July 2019 to December 2019, her pulmonary function gradually improved from 1.39 L to a peak of 1.62 L (64% predicted); her chest CT scan was unremarkable.  Figure 2 illustrates the patient's pulmonary function after both her primary and redo transplant.